Seiji Kageyama - Concepedia

Author

Seiji Kageyama

Tohoku Medical and Pharmaceutical University ORCID

Also Known As

Kageyama Seiji, Kageyama, Seiji, Katsushi Tokunaga, Masayuk Shima, Masayuki Shima, S KAGEYAMA, S Kageyama, S. Kageyama, SEIJI KAGEYAMA, Seiji Kageyama

144

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Tohoku Medical and Pharmaceutical University Kanazawa University Tottori University National Cancer Institute Kenya Medical Research Institute

About

Seiji Kageyama is an author at Tohoku Medical and Pharmaceutical University specializing in medicine, virology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	975
2	Public Health	8	8	235
3	Engineering	2	2	69
4	Health Sciences	1	1	29
5	Natural Sciences	1	1	63

Seiji Kageyama

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Therapeutic basis of glycyrrhizin on chronic hepatitis B Wakana Goto, Jun‐ichi Yamamura, Masako Kurokawa, Antiviral Research HepatologyTherapeutic BasisViral HepatitisMedicineImmunology	1996	185
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine Seiji Kageyama, Tsutomu Mimoto, Yasuhiko Murakawa, Antimicrobial Agents and Chemotherapy	1993	111
Prophylactic treatment of cytomegalovirus infection with traditional herbs Tomoyo A. Yukawa, Masahiko Kurokawa, Hitoshi Sato, Antiviral Research MedicineAntiviral TherapyTraditional HerbsVirology	1996	96
A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines Seiji Kageyama, Dorothy M. Agdamag, Evelyn T. Alesna, Journal of Medical Virology	2006	96
Plasma HIV-1 Viremia in HIV-1 Infected Individuals Assessed by Polymerase Chain Reaction Shizuko Sei, Robert Yarchoan, Seiji Kageyama, AIDS Research and Human Retroviruses	1992	77
Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins Seiji Kageyama, Barry Anderson, Barbara L. Hoesterey, Antimicrobial Agents and Chemotherapy High ConcentrationsImmunologyAntiviral DrugHuman Immunodeficiency VirusHuman Retrovirus	1994	63
Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia Afiono Agung Prasetyo, Paramasari Dirgahayu, Yulia Sari, The Journal of Infection in Developing Countries	2013	62
Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock Naoki Matsuda, Y. Takano, Seiji Kageyama, Cardiovascular Research	2007	60
In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations Seiji Kageyama, John N. Weinstein, T Shirasaka, Antimicrobial Agents and Chemotherapy Hiv Protease InhibitorsImmunologyAntiviral DrugHuman Immunodeficiency VirusImmunotherapy	1992	57
Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. Neil R. Hartman, Gurpreet S. Ahluwalia, David A. Cooney, Molecular Pharmacology	1991	51

Page 1